The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,024.00
Bid: 2,022.00
Ask: 2,026.00
Change: 12.00 (0.60%)
Spread: 4.00 (0.198%)
Open: 2,014.00
High: 2,024.00
Low: 2,012.00
Prev. Close: 2,012.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BRIEFING: Pearson has positive first quarter, buys language app

Fri, 29th Apr 2022 08:25

(Alliance News) - Educational materials publisher Pearson on Friday provided a positive update on first quarter trading, while also announcing a new acquisition.

Pearson has agreed to buy Mondly, an online language learning platform. It provided no financial details, but said it expects the purchase to accelerate revenue growth for its English Language Learning division from 2023 onward. It expects mid-teens margins for the division by 2025.

"Mondly is a fast growing and profitable business that expands our reach and scale in the language learning market and drives growth for the company," said Pearson Chief Executive Andy Bird. "This acquisition is strategically important to the group as well as being accretive and driving shareholder returns."

Mondly offers learning of English and 40 other languages via its app and other digital products, including virtual reality.

Turning to its own recent trading, Pearson reported underlying sales growth of 7% in the first quarter. It reaffirmed its guidance for adjust operating profit in 2022.

Pearson added that its GBP350 million share buyback programme has begun, with GBP75 million already completed.

Pearson shares were up 2.2% early Friday.

Here is what you need to know at the London market open:

----------

MARKETS

----------

FTSE 100: up 0.5% at 7,545.66

----------

Hang Seng: up 3.4% at 20,959.08

Nikkei 225: Tokyo market closed for holiday

S&P/ASX 200: closed up 1.1% at 7,435.00

----------

DJIA: closed up 614.46 points, or 1.9%, at 33,916.39

S&P 500: closed up 103.54 points, or 2.5%, at 4,287.50

Nasdaq Composite: closed up 382.59 points, or 3.1%, at 12,871.53

----------

EUR: up at USD1.0542 (USD1.0524)

GBP: up at USD1.2530 (USD1.2458)

USD: down at JPY130.29 (JPY131.00)

Gold: up at USD1,911.36 per ounce (USD1,887.75)

Oil (Brent): up at USD108.39 a barrel (USD106.55)

(changes since previous London equities close)

----------

ECONOMICS AND GENERAL

----------

Friday's key economic events still to come

Japan Showa Day. Financial markets closed.

1100 CEST EU gross domestic product

1100 CEST EU consumer price index

0830 EDT US personal income & outlays

1000 EDT US University of Michigan survey of consumers

----------

Annual UK house price growth slowed slightly in April but remained robust, according to figures from mortgage lender Nationwide. UK house prices rose 12% year-on-year in April, slowing from March's 14% climb. "Nevertheless, this is the 11th time in the past 12 months that the annual growth rate has been in double digits," Nationwide analyst Robert Gardner commented. On a monthly basis, the average UK house price climbed 0.3% to GBP267,620, from GBP265,312. In March, prices had risen 1.1% monthly. Gardner added: "Housing market activity has remained solid with mortgage approvals continuing to run above pre-Covid levels. Demand is being supported by robust labour market conditions, where employment growth has remained strong and the unemployment rate has fallen back to pre-pandemic lows."

----------

Ukrainian President Volodymyr Zelensky welcomed further US financial support as a "very important step". Zelensky thanked both US President Joe Biden and the American people for their help, expressing hope that the US Congress would "quickly support" the USD33 billion boost. "President Biden rightly said today that this step is not cheap," Zelensky said in his daily video address. "But the negative consequences of Russia's aggression against Ukraine and against democracy are so large-scale for the whole world that, in comparison with them, this support from the US is necessary. Together, we can certainly stop Russian aggression and reliably defend freedom in Europe." Of the latest sum, USD20 billion would be used for military aid while USD8.5 billion would be provided for economic aid. The US has pledged or already delivered weapons and ammunition worth more than USD3.7 billion to Ukraine since Moscow's attacks began in late February.

----------

BROKER RATING CHANGES

----------

JPMorgan cuts J Sainsbury price target to 190 (230) pence - 'underweight'

----------

RBC cuts Oxford Nanopore Technologies price target to 400 (700) pence - 'outperform'

----------

COMPANIES - FTSE 100

----------

NatWest rounded off the UK blue-chip banking earnings season with a slight flourish. Total income in the three months to March 31 climbed 17% annually to GBP3.03 billion from GBP2.59 billion. Operating pretax profit jumped 96% to GBP1.25 billion from GBP635 million. The lender expects to meet annual guidance, though there is an improved outlook for its 'Go-Forward' businesses, which exclude Ulster Bank Republic of Ireland. NatWest now expects total income, excluding notable items, at the "Go-Forward" units to be "comfortably above" GBP11.0 billion. Back in February, it only expected total income "above GBP11.0 billion", not "comfortably above". In addition, on Friday, AIB said it has entered into exclusive talks with NatWest to acquire EUR6 billion in Ulster Bank performing tracker mortgages. "Any potential transaction remains subject to negotiations and agreement," AIB added.

----------

Pharmaceutical firm AstraZeneca's got a boost from its acquisition of Alexion. AstraZeneca said its total revenue in the first three months of 2022 surged 56% to USD11.39 billion. The drugmaker's reported earnings per share fell 79% yearly, however, to USD0.25. Core EPS, which excludes acquisition-related items, amortisation of intangibles, impairments, and restructuring charges, was 16% higher at USD1.89. Astra said the revenue surge reflected "growth across the company, the contribution of the Alexion medicines and several Vaxzevria contracts that are expected to complete delivery by half year 2022". AstraZeneca completed its USD39 billion takeover of Boston-based rare diseases firm Alexion Pharmaceuticals in July last year. Astra backed annual guidance. It tips revenue to rise "by a high teens percentage" and core EPS to climb by a "mid-to-high twenties percentage". Both growth rates are at constant currency. Astra has not given any guidance on a reported basis. It also said it plans to launch a new R&D site in Cambridge, Massachusetts.

----------

Generic drug maker Hikma Pharmaceuticals raised guidance for its key Injectables business due to the contribution from its acquisition of Custopharm. Back in September, Hikma agreed to buy the California-based generic injectable products company for a total of up to USD425 million. The deal added up to 13 approved products to Hikma's portfolio. The company said it now expects Injectables revenue growth in mid-to-high single digits in 2022, up from previous guidance of low-to-mid single digits. Generics revenue is expected to grow by 8% to 10% in 2022, while Branded revenue is expected to be in line with 2021.

----------

Reckitt Benckiser reported a slight revenue fall in the first quarter of 2022 but said it expects 2022 like-for-like net revenue growth at the upper end of its 1% to 4% guidance. "Despite significant cost inflation, we expect adjusted operating margins in-line with prior year and current market expectations," the Dettol and Air Wick owner said. Net revenue in the first quarter fell 2.3% year-on-year to GBP3.42 billion. On a like-for-like basis, it was up 5.6%. Hygiene arm revenue fell 9.0% like-for-like, though Nutrition surged 20% and Health jumped 21%.

----------

Oil major BP will partner with German automaker Volkswagen to "boost" adoption of electric vehicles across Europe. The pair plans to "rapidly" build fast-charging EV network across Europe by 2024. "Volkswagen's innovative Flexpole 150,000 watts charging units, each of which features two charge points, have an integrated battery storage system, overcoming one of the biggest obstacles to the rapid roll-out of fast charging infrastructure in Europe today – the need for high-powered grid connections," VW explained. First phase of the roll-out will see up to an additional 4,000 charge points at BP's Aral retail sites in Germany and BP retail sites in the UK over the next 24 months. The paid hope to make 8,000 charge points available across Europe by end of 2024.

----------

COMPANIES - SMALL CAP

----------

Electrical goods seller AO World said it is "cautious" about its revenue and profit outlook, amid supply chain pressures and the impact of inflation. In the year ended March 31, group revenue fell 6% year-on-year, though was up 52% from two years prior. A strategic review launched in January is continuing, AO World added.

----------

Building materials company Kingspan said first-quarter revenue surged, though inflationary pressures, which had ebbed slightly at the turn of the year, have returned in recent weeks. Kingspan's revenue in the first quarter of 2022 jumped 47% year-on-year to EUR1.89 billion. "Raw material inflation which had eased considerably at the turn of the year has returned sharply over the past six weeks and the associated recovery effort is ongoing," it cautioned. "The group's trading outlook for the second quarter is positive with a strong order backlog on hand and decent activity in most end-markets. Raw material inflation remains an issue to be firmly managed, coming on the back of a highly inflationary year in 2021."

----------

COMPANIES - GLOBAL

----------

BASF said first-quarter profit was hit by Russia-related impairment charges, despite healthy growth in sales. The Ludwigshafen, Germany-based chemical company said that, in the first quarter, sales grew 19% year-on-year to EUR23.08 billion from EUR19.40 billion. This was mainly driven by higher prices, notably in the Chemicals and Materials segments, which was somewhat offset by slightly lower sales volumes, BASF said. Earnings before interest and tax rose 19% to EUR2.8 billion, but pretax profit dropped 16% to EUR1.88 billion from EUR2.25 billion in the first quarter of 2021. The drop was due to impairment charges from Wintershall Dea, which caused a decline in income from shareholdings of EUR1.1 billion. The charges were caused by the war in Ukraine, and concerned assets in Russia and the gas transportation business.

----------

Friday's shareholder meetings

ADVFN PLC - GM re director appointments

AstraZeneca PLC - AGM

BBGI Global Infrastructure SA - AGM

GreenCoat Renewables PLC - AGM

Holders Technology PLC - AGM

HSBC Holdings PLC - AGM

JPMorgan Claverhouse Investment Trust PLC - AGM

Kingspan Group PLC - AGM

Minoan Group PLC - AGM

Nostrum Oil & Gas PLC - GM - re notes restructuring

Pearson PLC - AGM

Photo-Me International PLC - AGM

Rotork PLC - AGM

Smurfit Kappa Group PLC - AGM

Travis Perkins PLC - AGM

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
5 Aug 2022 09:43

Barclays downgrades Hikma to 'equalweight' on Generics concerns

(Sharecast News) - Barclays downgraded Hikma Pharmaceuticals on Friday to 'equalweight' from 'overweight' and cut the price target to 1,750p from 2,250p as it said a lack of visibility in the generics division was a real concern.

Read more
5 Aug 2022 08:15

LONDON BRIEFING: London Stock Exchange benefits from market volatility

(Alliance News) - London Stock Exchange Group on Friday said results in the first half of 2022 improved, as this year's interim period had an extra month's worth of contribution from recent acquisition Refinitiv.

Read more
4 Aug 2022 17:05

LONDON MARKET CLOSE: Stocks shrug off BoE's UK recession warning

(Alliance News) - Stocks in London managed to end higher on Thursday despite a bleak warning from the Bank of England regarding to outlook for the UK economy as it jacked up rates by 50 basis points.

Read more
4 Aug 2022 12:09

LONDON MARKET MIDDAY: BoE hikes, expects UK recession in 4th quarter

(Alliance News) - London shares price made some gains on Thursday morning, though these fell well short of the market rise seen on mainland Europe, as traders in London showed signs of trepidation leading up to the Bank of England's interest rate decision.

Read more
4 Aug 2022 10:15

Hikma revenue flat, profits tumble in first half

(Sharecast News) - Hikma shares were tumbling on Thursday morning after the pharmaceuticals company reported flat group revenue in its first half, at $1.21bn, as it slashed its guidance on its lagging generics business.

Read more
4 Aug 2022 09:01

LONDON MARKET OPEN: FTSE 100 underperforms amid pre-BoE trepidation

(Alliance News) - The FTSE 100 underperformed European peers and traded sideways in early dealings on Thursday, with the Bank of England to take centre-stage during a week that so far has been dominated by tensions between the US and China.

Read more
4 Aug 2022 09:00

TOP NEWS: Hikma first half hit by stiff competition for Generics

(Alliance News) - Hikma Pharmaceuticals PLC shares suffered on Thursday, as it lowered annual guidance after a poor performance in its Generics business hit half-year profit.

Read more
4 Aug 2022 07:54

LONDON MARKET PRE-OPEN: Next and Serco up outlook but Hikma lowers

(Alliance News) - Stock prices in London are seen opening ever-so-slightly higher, falling short of the more convincing gains seen in Asia, with investors wary ahead of the latest Bank of England interest rate decision.

Read more
28 Jul 2022 16:06

UK earnings, trading statements calendar - next 7 days

Friday 29 July 
Allianz Technology Trust PLCHalf Year Results
Aston Martin Lagonda Global Holdings PLCHalf Year Results
AstraZeneca PLCHalf Year Results
Babcock International Group PLCFull Year Results
CMC Markets PLCTrading Statement
Croda International PLCHalf Year Results
Glencore PLCTrading Statement
Jupiter Fund Management PLCHalf Year Results
IMI PLCHalf Year Results
Impellam Group PLCHalf Year Results
Industrials REIT LtdTrading Statement
International Consolidated Airlines Group SAHalf Year Results
Intertek Group PLCHalf Year Results
Law Debenture Corp PLCHalf Year Results
Morgan Advanced Materials PLCHalf Year Results
NatWest Group PLCHalf Year Results
Premier Miton Global Renewables Trust PLCHalf Year Results
Rightmove PLCHalf Year Results
Shearwater Group PLCFull Year Results
Standard Chartered PLCHalf Year Results
Walker Crips Group PLCFull Year Results
YouGov PLCTrading Statement
Monday 1 August 
Ascential PLCHalf Year Results
Cranswick PLCQ1 Results
Dialight PLCHalf Year Results
GlobalData PLCHalf Year Results
HSBC Holdings PLCHalf Year Results
Hutchmed (China) LtdHalf Year Results
NAHL Group PLCTrading Statement
Pearson PLCHalf Year Results
Senior PLCHalf Year Results
Seraphine Group PLCFull Year Results
Spectris PLCHalf Year Results
XP Power PLCHalf Year Results
Tuesday 2 August 
BP PLCHalf Year Results
Capital & Counties Properties PLCHalf Year Results
Coats Group PLCHalf Year Results
Devro PLCHalf Year Results
Direct Line Insurance Group PLCHalf Year Results
Domino's Pizza Group PLCHalf Year Results
Fresnillo PLCHalf Year Results
Greggs PLCHalf Year Results
Keller Group PLCHalf Year Results
Man Group PLCHalf Year Results
Rotork PLCHalf Year Results
Sage Group PLCQ3 Results
Staffline Group PLCHalf Year Results
Synthomer PLCHalf Year Results
Travis Perkins PLCHalf Year Results
Virgin Money UK PLCQ3 Results
Wednesday 3 August 
Endeavour Mining PLCHalf Year Results
Ferrexpo PLCHalf Year Results
Hill & Smith Holdings PLCHalf Year Results
Hiscox LtdHalf Year Results
IP Group PLCHalf year Results
LSL Property Services PLCHalf Year Results
Taylor Wimpey PLCHalf Year Results
Thursday 4 August 
Coca-Cola Europacific Partners PLCHalf Year Results
ConvaTec Group PLCHalf Year Results
Evraz PLCHalf Year Results
Glencore PLCHalf Year Results
Gym Group PLCHalf Year Results
Hikma Pharmaceuticals PLCHalf Year Results
Meggitt PLCHalf Year Results
Mondi PLCHalf Year Results
Morgan Sindall Group PLCHalf Year Results
Next PLCTrading Statement
Pantheon International PLCFull Year Results
Revolution Beauty Group PLCFull Year Results
Rolls-Royce Holdings PLCHalf Year Results
ScS Group PLCTrading Statement
Secure Trust Bank PLCHalf Year Results
Serco Group PLCHalf Year Results
Spirent Communications PLCHalf Year Results
Tritax Big Box REIT PLCHalf Year Results
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
18 Jul 2022 09:46

LONDON BROKER RATINGS: Trio of downgrades for Fevertree; Admiral cut

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
13 Jul 2022 10:02

LONDON BROKER RATINGS: Jefferies likes Tyman; UBS cuts Beazley

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
25 May 2022 10:05

LONDON BROKER RATINGS: JPMorgan cuts Hikma; Liberum likes Trustpilot

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
25 May 2022 08:28

LONDON BRIEFING: M&S warns on cost hit to profit but is well placed

(Alliance News) - Marks & Spencer on Wednesday reported a swing to profit for the year ended April 2, but the clothing, homewares and food retailer cautioned on profit in the year ahead, amid the war in Ukraine and investment plans.

Read more
24 May 2022 10:29

IN BRIEF: Hikma Pharmaceuticals Chief Executive Siggi Olafsson resigns

Hikma Pharmaceuticals PLC - London-based pharmaceutical company - Says Siggi Olafsson has resigned as chief executive officer and from the board to "pursue other opportunities." Adds he will remain available to the company until he resigns on June 24. Olafsson was appointed as CEO in 2018. Before he joined Hikma, he was president of peer firm Actavis Generics until 2014 from 2012.

Read more
24 May 2022 08:24

LONDON BRIEFING: Barclays launches delayed GBP1 billion share buyback

(Alliance News) - Barclays said it will kick off a GBP1.00 billion share buyback programme on Tuesday. The programme, initially announced in February, had been delayed in March after the bank admitted it sold more financial products to investors than it was allowed to.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.